Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Urinary Bladder Neoplasms 26Non-Muscle Invasive Bladder Neoplasms 11Colorectal Neoplasms 3Colonic Neoplasms 3Recurrence 2Neoplasms 2Melanoma 2Lung Neoplasms 2Side Effect of Drug 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Osteosarcoma 1Oligospermia 1Neuroblastoma 1Fibrosis 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma in Situ 1Breast Neoplasms 1

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 35Peripheral Blood Stem Cell Transplantation 31dinutuximab 29Radiotherapy 29Granulocyte Colony-Stimulating Factor 29sargramostim 283-Iodobenzylguanidine 27Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16Ifosfamide 15naxitamab 14fludarabine phosphate 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuroblastoma × BCG Vaccine × Clear all
NCT00003023 2013-01-18

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
24 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡